Delivery Order SPE2DB22D3016-SPE2DB24FAYQ5

Award Date 6/17/24
Potential Completion Date 7/10/24
Potential Value $24K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract worth $48,621.84 to provide VYVGART 400 MG/20 ML VIAL 20ML pharmaceutical products. This contract has a completion date of March 12, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor for this award. This delivery order contract is issued under a larger indefinite delivery contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract has a potential value of $8,103.66 and a completion date of March 25, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, with a potential value of up to...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a division of Amerisourcebergen Corporation, for the supply of VYVGART 400 MG/20 ML VIAL 20ML pharmaceutical products. The contract has a potential value of $16,207.28 and a completion date of February 23, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor on this award and serves as a supplier of pharmaceuticals and medical supplies to...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $25,585.02, is for the delivery of VYVGART 400 MG/20 ML VIAL 20ML, a pharmaceutical product. The contract is a firm fixed price delivery order with a period of performance through March 31, 2025. The contract was not set aside for any specific business type. AmerisourceBergen holds a significant...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide VYVGART 400 MG/20 ML VIAL 20ML, a pharmaceutical product, with a potential value of $8,103.66. The contract has a completion date of March 13, 2024. Amerisourcebergen Drug Corp has also been awarded an Indefinite Delivery Contract (IDC) by DLA to provide a comprehensive range of pharmaceutical products and medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $34,113.36, is for the provision of VYVGART 400 MG/20 ML VIAL 20ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of February 12, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $8,103.66 firm fixed price delivery order is for the supply of VYVGART 400 MG/20 ML VIAL 20ML, a pharmaceutical product. The contract has a completion date of March 8, 2024 and was awarded on February 15, 2024. This award is part of Amerisourcebergen Drug Corp's broader role as the prime contractor on...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $23,976.78 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) for 400 mg/20 ml vials of the pharmaceutical product VYVGART. This delivery order has a completion date of November 17, 2023. Amerisourcebergen Drug Corp serves as a prime contractor providing pharmaceutical products and medical supplies to U.S. government agencies, including the Department of Defense. The company...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, with a ceiling value of $25,585.02, is for the delivery of VYVGART 400 MG/20 ML VIAL 20ML, a pharmaceutical product. This is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $16,207.28 firm fixed price delivery order is for the supply of VYVGART 400 MG/20 ML VIAL 20ML, a pharmaceutical product. The award is part of a larger indefinite delivery contract (IDC) issued by DLA to Amerisourcebergen Drug Corp, with a potential value of...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB24FAYQ5
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company, to provide 4564949277 VYVGART 400 MG/20 ML VIAL 20ML. The contract, valued at $24,310.92, has a completion date of July 10, 2024. Amerisourcebergen also holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, the primary vehicle for delivering a range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. Additionally, the company holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This contract was awarded on a full and open competition basis without a set-aside designation.

Generated 9/16/24, 10:38 AM